United States Patent and Trademark Fee Modernization Act of 2004

H.R.1561-United States Patent and Trademark Fee Modernization Act of 2003, all provisions.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Pl-107-250-Medical Device User Fee and Modernization Act of 2002. (Bill that became the law to finance faster FDA reviews of new medical devices and to make improvements in the regulation of medical devices.) H.R.3493/S.1881-Medical Devices Technical Corrections Act. (Bills to make technical corrections relating to the amendments made by the Medical Device User Fee and Modernizatoin Act of 2002.) S.15/H.R.2122-Project BioShield Act of 2003. S.754-Improved Vaccine Affordability and Availability Act. (Bills to enhance, research, development, procurement, and use of biomedical countermeasures to respond to public health threats affecting national security.) S.877-Patient Safety Improvement Act of 2003. H.R. 663/S.720-Patient Safety and Quality Improvement Act. S. 1775/H.R. 3038-Healthcare Safety Net Amendments Technical Corrections Act of 2003. (Bills intended to provide for the improvement of patient safety and to reduce the incidence of medical errors that adversely affect patient safety.) H.R.5-Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003. S.11-Patients First Act of 2003. (Bills to improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.) H.R.3140 (PL 108-164)/H.R.2221-Fairness to Contact Lens Consumers Act. H.R.2218/S.1747-To Amend Food and Drug, and Cosmetic Act to Provide for the regulation of all contact lenses as medical devices, and for other purposes. (Bills to regulate all contact lenses as medical devices.) S. Con. Res.80/H. Con. Res. 324-Concurrent resolution urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreeement on Medical Equipment and Pharmaceuticals, and for other purposes. (Bills providing that the revolution in medical technology has improved our ability to respond to emerging threats and prevent, identify, treat, and cure a broad range of diseases and disabilities, and has the proven potential to bring even more valuable advances in the future.) H.R.1828-Syria Accountability and Lebanese Sovereignty Restoration Act of 2003. (Section of the bill related to lifting sanctions against export of medical devices as related to Syria and Lebanon.) H.R.1561-United States Patent and Trademark Fee Modernizaton Act of 2003. (The bill to lower patent filing and basic national fees as related to medical devices.)

Client expense: $2,440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office